These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 677118)

  • 1. Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia.
    Chikkappa G; Carsten AL; Chanana AD; Chandra P; Cronkite EP
    Am J Hematol; 1978; 4(2):121-31. PubMed ID: 677118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased erythrocytic and neutrophilic progenitors in myelofibrosis with myeloid metaplasia.
    Ohl S; Carsten AL; Chanana AD; Chikkappa G; Cronkite EP
    Eur J Cancer (1965); 1976 Feb; 12(2):131-5. PubMed ID: 1063073
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
    Mesa RA; Li CY; Schroeder G; Tefferi A
    Blood; 2001 Jun; 97(11):3665-7. PubMed ID: 11369668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A; Gray LA; Reeder T; Schroeder G; Kaufmann SH
    Leukemia; 2003 May; 17(5):849-55. PubMed ID: 12750696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal analysis of agnogenic myeloid metaplasia.
    Kreipe H; Jaquet K; Felgner J; Parwaresch MR
    Leuk Lymphoma; 1992 Dec; 8(6):459-64. PubMed ID: 1363649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia.
    Kreipe H; Jaquet K; Felgner J; Radzun HJ; Parwaresch MR
    Blood; 1991 Oct; 78(7):1814-7. PubMed ID: 1680495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis.
    Han ZC; Briere J; Nedellec G; Abgrall JF; Sensebe L; Parent D; Guern G
    Eur J Haematol; 1988 Feb; 40(2):130-5. PubMed ID: 3345826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood and spleen haematopoiesis in patients with myelofibrosis.
    Douay L; Laporte JP; Lefrancois G; Najman A; Dupuy-Montbrun MC; Lopez M; Giarratana MC; Gorin NC
    Leuk Res; 1987; 11(8):725-30. PubMed ID: 3626614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of proliferation and differentiation of human hemopoietic cells in a diffusion chamber system.
    Chikkappa G; Carsten AL; Cronkite EP
    Exp Hematol; 1980 May; 8(5):533-40. PubMed ID: 6936262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic progenitor cells in a patient with myeloid metaplasia without myelofibrosis.
    Kubota K; Tamura J; Kurabayashi H; Murakami H; Naruse T; Tsuchiya J
    J Med; 1992; 23(2):149-53. PubMed ID: 1512522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marrow fibrosis does not account for circulating CD34+ cells in myelofibrosis with myeloid metaplasia.
    Samuelson SJ; Popat U; Prchal JT
    Haematologica; 2007 Apr; 92(4):e47. PubMed ID: 17405759
    [No Abstract]   [Full Text] [Related]  

  • 13. IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis.
    Emadi S; Clay D; Desterke C; Guerton B; Maquarre E; Charpentier A; Jasmin C; Le Bousse-Kerdilès MC;
    Blood; 2005 Jan; 105(2):464-73. PubMed ID: 15454487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating erythroid progenitors in patients with 'spent' polycythaemia vera and myelofibrosis with myeloid metaplasia.
    Kornberg A; Fibach E; Treves A; Goldfarb A; Rachmilewitz EA
    Br J Haematol; 1982 Dec; 52(4):573-8. PubMed ID: 7138787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of myelofibrosis with myeloid metaplasia.
    Tefferi A
    J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia.
    Zauli G; Visani G; Catani L; Vianelli N; Gugliotta L; Capitani S
    Br J Haematol; 1993 Jan; 83(1):14-20. PubMed ID: 8435322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia.
    Barosi G; Rosti V; Massa M; Viarengo GL; Pecci A; Necchi V; Ramaioli I; Campanelli R; Marchetti M; Bazzan M; Magrini U
    Br J Haematol; 2004 Mar; 124(5):618-25. PubMed ID: 14871248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered transcription of the stem cell leukemia gene in myelofibrosis with myeloid metaplasia.
    Steunou V; Le Bousse-Kerdilès MC; Colin-Micouin A; Clay D; Chevillard S; Martyré MC;
    Leukemia; 2003 Oct; 17(10):1998-2006. PubMed ID: 14513050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype of blast cells in acute myelofibrosis.
    Ortuño F; Soler J; Vilella R; Bordes R; Guanyabens C; Rubiol E; Pujol-Moix N
    Leuk Res; 1990; 14(10):849-56. PubMed ID: 2259222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell aplasia in myelofibrosis with myeloid metaplasia. A distinct functional and clinical entity.
    Barosi G; Baraldi A; Cazzola M; Spriano P; Magrini U
    Cancer; 1983 Oct; 52(7):1290-6. PubMed ID: 6192899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.